Evogene Signals Possible U.S. Listing as Israel ‘Not Enough’David Wainer
Evogene Ltd., which uses plant genomics to develop products for the agriculture and biofuel industries, is weighing additional listings as the company seeks to draw investors from abroad.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.
- This $14 Million Atlanta Home With Bunker Is ‘Safest in America’
- GE's New CEO Vows Sweeping Change After ‘Unacceptable’ Report
- These Cities Make NYC Housing Look Dirt Cheap
- Separatists Pledge to Fight On After Spain Moves to Oust Catalan Leaders
- The U.K.'s $86 Billion Pension Problem Is About to Solve Itself